Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-4.00 Insider Own35.63% Shs Outstand72.90M Perf Week14.30%
Market Cap1.20B Forward P/E- EPS next Y-4.03 Insider Trans3.55% Shs Float48.18M Perf Month1.58%
Income-293.46M PEG- EPS next Q-1.02 Inst Own65.86% Short Float / Ratio12.50% / 8.16 Perf Quarter-24.20%
Sales119.66M P/S10.05 EPS this Y-8.14% Inst Trans-0.86% Short Interest6.02M Perf Half Y-23.51%
Book/sh6.95 P/B2.31 EPS next Y-0.50% ROA-22.71% Target Price40.67 Perf Year-54.31%
Cash/sh10.67 P/C1.51 EPS next 5Y- ROE-48.16% 52W Range12.95 - 36.13 Perf YTD-22.29%
Dividend- P/FCF- EPS past 5Y-25.04% ROI-56.43% 52W High-55.52% Beta0.69
Dividend %- Quick Ratio4.41 Sales past 5Y262.14% Gross Margin87.94% 52W Low24.09% ATR0.88
Employees500 Current Ratio4.41 Sales Q/Q-4.71% Oper. Margin-270.31% RSI (14)58.94 Volatility5.73% 6.08%
OptionableYes Debt/Eq0.02 EPS Q/Q-5.90% Profit Margin-245.25% Rel Volume1.07 Prev Close15.06
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume737.41K Price16.07
Recom1.50 SMA2010.09% SMA501.12% SMA200-12.55% Volume791,397 Change6.71%
Date Action Analyst Rating Change Price Target Change
Nov-18-22Initiated BofA Securities Neutral $33
Oct-11-22Initiated Morgan Stanley Overweight $40
Oct-15-21Resumed BTIG Research Buy $57
Nov-24-20Initiated Berenberg Buy $50
Nov-23-20Initiated Evercore ISI Outperform
Apr-03-20Initiated Cantor Fitzgerald Overweight $21
Mar-04-20Initiated Barclays Overweight $24
Nov-12-19Initiated SunTrust Buy $20
Sep-27-19Initiated Mizuho Buy $22
May-24-19Resumed Citigroup Buy $25
Nov-27-23 04:35PM
Nov-14-23 04:00PM
Nov-13-23 04:35PM
Nov-08-23 04:05PM
Nov-07-23 04:01PM
05:00PM Loading…
Nov-06-23 05:00PM
Oct-31-23 10:01AM
Oct-24-23 04:35PM
Oct-17-23 04:00PM
Oct-10-23 04:35PM
Sep-27-23 05:14AM
Sep-26-23 04:35PM
Sep-11-23 04:35PM
Sep-05-23 07:37PM
Aug-24-23 04:35PM
11:30AM Loading…
Aug-23-23 11:39AM
Aug-09-23 04:35PM
Aug-07-23 09:15AM
Aug-03-23 05:55PM
Aug-02-23 05:25PM
Aug-01-23 05:45PM
Jul-25-23 04:35PM
Jul-11-23 04:35PM
Jul-03-23 06:50AM
Jun-26-23 04:35PM
Jun-21-23 08:00PM
12:08PM Loading…
Jun-12-23 12:08PM
Jun-09-23 04:35PM
Jun-05-23 02:59PM
Jun-03-23 01:30PM
May-30-23 04:00PM
May-26-23 04:05PM
May-24-23 04:35PM
May-17-23 08:30AM
May-16-23 11:51AM
May-15-23 08:30AM
May-11-23 09:44AM
May-09-23 06:15PM
May-08-23 04:35PM
May-05-23 12:45PM
May-04-23 12:04PM
May-03-23 01:47PM
May-01-23 10:00AM
Apr-26-23 08:00PM
Apr-25-23 04:05PM
Apr-19-23 11:17AM
Apr-11-23 04:05PM
Mar-09-23 04:05PM
Mar-06-23 12:33PM
Mar-03-23 02:20PM
Mar-02-23 04:00PM
Feb-28-23 05:35PM
Feb-24-23 04:05PM
Feb-23-23 01:41PM
Feb-17-23 12:24PM
Feb-15-23 10:57AM
Feb-14-23 06:33AM
Feb-09-23 04:05PM
Feb-08-23 10:53AM
Feb-07-23 12:17PM
Feb-06-23 04:05PM
Feb-03-23 02:02PM
Jan-30-23 10:00AM
Jan-25-23 10:21AM
Jan-24-23 04:05PM
Jan-23-23 11:01AM
Jan-20-23 07:34AM
Jan-18-23 12:45PM
Jan-12-23 12:38PM
Jan-10-23 04:05PM
Dec-23-22 08:00PM
Dec-22-22 08:07AM
Dec-20-22 04:07PM
Dec-19-22 05:00PM
Dec-09-22 04:05PM
Dec-02-22 10:03AM
Nov-29-22 10:14AM
Nov-28-22 04:14PM
Nov-14-22 04:05PM
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jarrett JenniferChief Operating OfficerSep 22Sale19.9921,369427,166302,691Sep 26 04:35 PM
Jarrett JenniferChief Operating OfficerJul 28Sale20.2545,000911,250336,566Jul 31 04:15 PM
Azoy AlexanderChief Accounting OfficerJul 03Sale20.411,01820,77711,596Jul 05 04:05 PM
GILEAD SCIENCES, INC.10% OwnerJun 28Buy19.261,010,00019,452,60014,823,029Jun 30 03:12 PM
Jarrett JenniferChief Operating OfficerJun 22Sale19.1212,437237,795381,566Jun 26 04:36 PM
Jarrett JenniferChief Operating OfficerJun 16Sale19.3512,563243,094394,003Jun 16 08:16 PM
Goeltz II Robert C.Chief Financial OfficerJun 07Sale20.044,04981,14259,392Jun 09 04:05 PM
Jarrett JenniferChief Operating OfficerMar 16Sale16.818,729146,734406,217Mar 20 04:12 PM
Jarrett JenniferChief Operating OfficerJan 27Sale23.521,60037,632414,946Jan 30 05:04 PM
Jarrett JenniferChief Operating OfficerJan 26Sale23.563007,068416,546Jan 30 05:04 PM
Jarrett JenniferChief Operating OfficerDec 16Sale30.7516,482506,822147,609Dec 16 09:41 PM
ROSEN TERRY JChief Executive OfficerDec 16Sale30.7513,043401,073242,173Dec 16 09:39 PM
Jaen Juan C.PresidentDec 16Sale30.754,436136,407218,258Dec 16 09:40 PM
Tang Carolyn C.General CounselDec 16Sale30.752,52377,58228,584Dec 16 09:42 PM
Goeltz II Robert C.Chief Financial OfficerDec 16Sale30.752,45375,43011,566Dec 16 09:44 PM